Skip to main content

Breadcrumb

  1. Home

Cardiovascular

Valid for Measure Submission

Cardiovascular

The Cardiovascular Standing Committee  oversees the consensus based entity's portfolio of Cardiovascular measures, which includes measures for acute myocardial infarction, percutaneous coronary intervention, ischemic vascular disease, heart failure, hypertension, rhythm disorders, and valvular heart disease.

Carotid Artery Stenting: Evaluation of Vital Status and NIH Stroke Scale at Follow Up

  • Proportion of patients with carotid artery stenting procedures who had follow up performed for evaluation of Vital Status and neurological assessment with an NIH Stroke Scale (by an examiner who is certified by the American Stroke
    Association) occurring between day 21 and the end of day 75 after the procedure. (Days 21-75 inclusive)

    CBE ID
    2396

Chronic Stable Coronary Artery Disease: Lipid Control

  • Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12 month period who have a LDL-C result <100 mg/dL OR patients who have a LDL-C result >=100 mg/dL and have a documented plan of care to achieve LDL-C <100mg/dL, including at a minimum the prescription of a statin

    CBE ID
    0074

Chronic Stable Coronary Artery Disease: Symptom and Activity Assessment

  • Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12 month period for whom there is documented results of an evaluation of level of activity AND an evaluation of presence or absence of anginal symptoms in the medical record

    CBE ID
    0065

Dyslipidemia new med 12-week lipid test

  • This measure identifies patients age 18 or older who started lipid-lowering medication during the measurement year and had a lipid panel checked within 3 months after starting drug therapy.

    CBE ID
    0583